News & Events

Subscribe to News & Events feed
Press releases from FDA
Updated: 2 hours 26 min ago

Statement from FDA Commissioner Scott Gottlieb, M.D., on findings from the romaine lettuce E. coli O157:H7 outbreak investigation and FDA’s efforts to prevent future outbreaks

Thu, 2018-11-01 13:24
Statement from FDA Commissioner Scott Gottlieb, M.D., on findings from the romaine lettuce E. coli O157:H7 outbreak investigation and FDA’s efforts to prevent future outbreaks

Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health on the National Toxicology Program’s report on radiofrequency energy exposure

Thu, 2018-11-01 09:30
Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program report release on radiofrequency energy exposure

FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

Wed, 2018-10-31 15:37
FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use

Wed, 2018-10-31 08:09
Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use.

FDA takes action to stop the use of lead acetate in hair dyes

Tue, 2018-10-30 10:10
FDA takes action to stop the use of lead acetate in hair dyes. FDA will no longer allow lead acetate to be used in certain hair coloring products based on data that demonstrate that there is no longer a reasonable certainty of no harm from the use of this color additive.

Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation

Tue, 2018-10-30 09:16
FDA announces new plan to advance the development of plant and animal biotechnology innovation

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies

Mon, 2018-10-29 08:15
Food allergies have touched the lives of most of us. Thousands of Americans experience life-threatening, food-related reactions each year, and an estimated 20 people die from them annually. In some cases, such reactions occur despite a careful reading of packaged food labels by conscientious consumers. To me, that’s unacceptable. The FDA is committed to advancing our efforts to help ensure that Americans have access to the information they need about common allergens in packaged foods.

FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

Wed, 2018-10-24 16:06
FDA permits marketing of a diagnostic test to aid in the determination of menopausal status

Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid...

Wed, 2018-10-24 14:23
The SUPPORT Act grants FDA additional authorities to meaningfully advance efforts to combat the crisis of opioid addiction plaguing our nation.

FDA approves new drug to treat influenza

Wed, 2018-10-24 11:08
FDA approved Xofluza (baloxavir marboxil) to treat acute uncomplicated flu in patients 12 years old and older who have been symptomatic for less than 48 hours.

Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer

Tue, 2018-10-23 12:06
A federal court orders a Tennessee-based company to stop selling over-the-counter (OTC) drug products

FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids

Tue, 2018-10-23 09:54
FDA warns website networks as part of global crack down for selling illegal pharmaceuticals

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths

Tue, 2018-10-23 08:20
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths

Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death

Mon, 2018-10-22 08:29
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death.

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, processors more effectively comply with food safety requirements

Fri, 2018-10-19 08:55
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, fresh-cut produce processors more effectively comply with food safety requirements

Trump Administration Launches “Winning on Reducing Food Waste” Initiative

Thu, 2018-10-18 16:01
The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the "Winning on Reducing Food Waste" initiative.

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies

Mon, 2018-10-15 09:33
FDA issues two guidance documents to provide drug developers greater clarity and direction as they pursue the next generation of therapies and treatments for patients.

FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy

Fri, 2018-10-12 09:11
FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy

Pages